IDEX (NYSE:IEX) Reaches New 1-Year High on Strong Earnings

Key Points

• IDEX hit a new 52-week high (intraday high $223.85) after reporting stronger-than-expected Q1 results — $2.00 EPS vs. $1.79 est. and $886.9M revenue, up 8.9% year-over-year.
• The company set Q2 2026 guidance of $2.07–2.12 and FY2026 guidance of $8.35–8.55, above consensus, while analysts have raised price targets (median ~$228.90 with several in the $240–$250 range).
• Investor activity is mixed: there was a small insider purchase and multiple institutional additions signaling confidence, but some large funds trimmed stakes; institutional ownership stands near 98%.

IDEX Corporation (NYSE:IEX - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Wednesday following a stronger than expected earnings report. The company traded as high as $223.85 and last traded at $218.4010, with a volume of 80817 shares traded. The stock had previously closed at $205.36.

The industrial products company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.79 by $0.21. IDEX had a return on equity of 15.03% and a net margin of 13.98%.The company had revenue of $886.90 million during the quarter, compared to the consensus estimate of $845.75 million. During the same period last year, the company earned $1.75 EPS. IDEX's revenue for the quarter was up 8.9% on a year-over-year basis. IDEX has set its Q2 2026 guidance at 2.070-2.120 EPS and its FY 2026 guidance at 8.350-8.550 EPS.

Key IDEX News

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Q1 results beat expectations: IDEX reported $2.00 EPS (vs. ~ $1.78–1.79 estimate) and revenue of $886.9M (up 8.9% YoY), driving proof of top-line growth and margin durability. Idex (IEX) Q1 Earnings and Revenues Top Estimates
• Positive Sentiment: Raised/affirmative guidance: IEX set FY2026 EPS guidance of $8.35–8.55, above consensus (~$8.26), and Q2 EPS guidance of $2.07–2.12 (around consensus). The outlook supports the beat and underpins upside to estimates. IDEX guidance and press materials
• Positive Sentiment: Analyst sentiment and upside: Recent analyst coverage shows above-consensus price targets (median ~$241) and several targets in the $240–$250 range, implying further upside from current levels. IDEX ($IEX) Releases Q1 2026 Earnings
• Positive Sentiment: Insider and institutional moves: QuiverQuant flags a recent insider purchase (600 shares) and several institutional investors materially adding positions, which can signal confidence from informed investors. IDEX ($IEX) Releases Q1 2026 Earnings
• Neutral Sentiment: Similar-name company update (not IEX): IDEX Biometrics (IDXAF) completed a NOK 80M private placement — this concerns a different company and can cause ticker confusion but is not directly relevant to IEX’s fundamentals. IDEX Biometrics Completes NOK 80 Million Private Placement
• Negative Sentiment: Mixed institutional flows: while some funds added large stakes, others (notably UBS AM) trimmed holdings substantially — heavy selling by large institutions can be a near-term headwind even after a beat. Also note limited recent congressional sales. IDEX ($IEX) Releases Q1 2026 Earnings

Analyst Upgrades and Downgrades

Several research firms recently commented on IEX. Oppenheimer reiterated an "outperform" rating and issued a $230.00 price objective on shares of IDEX in a report on Thursday, February 5th. TD Cowen lifted their price objective on IDEX from $200.00 to $250.00 and gave the stock a "buy" rating in a report on Thursday, February 5th. Citigroup lifted their price objective on IDEX from $202.00 to $243.00 and gave the stock a "buy" rating in a report on Thursday, February 5th. Robert W. Baird set a $247.00 price objective on IDEX in a report on Thursday, February 5th. Finally, DA Davidson raised their target price on IDEX from $180.00 to $195.00 and gave the stock a "neutral" rating in a research report on Thursday, February 5th. Six research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $228.90.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Empowered Funds LLC lifted its position in shares of IDEX by 3.4% during the 1st quarter. Empowered Funds LLC now owns 1,646 shares of the industrial products company's stock valued at $298,000 after buying an additional 54 shares in the last quarter. Cromwell Holdings LLC raised its stake in IDEX by 41.1% during the 4th quarter. Cromwell Holdings LLC now owns 199 shares of the industrial products company's stock valued at $35,000 after purchasing an additional 58 shares during the period. Evolve Private Wealth LLC raised its stake in IDEX by 2.8% during the 1st quarter. Evolve Private Wealth LLC now owns 2,125 shares of the industrial products company's stock valued at $403,000 after purchasing an additional 58 shares during the period. Mackenzie Financial Corp raised its stake in IDEX by 2.8% during the 4th quarter. Mackenzie Financial Corp now owns 2,562 shares of the industrial products company's stock valued at $458,000 after purchasing an additional 70 shares during the period. Finally, UMB Bank n.a. raised its stake in IDEX by 61.0% during the 3rd quarter. UMB Bank n.a. now owns 198 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 75 shares during the period. 97.96% of the stock is owned by hedge funds and other institutional investors.

IDEX Price Performance

The firm has a 50 day moving average of $198.63 and a 200-day moving average of $187.34. The company has a market cap of $16.16 billion, a P/E ratio of 33.92, a P/E/G ratio of 2.10 and a beta of 0.99. The company has a current ratio of 2.86, a quick ratio of 2.02 and a debt-to-equity ratio of 0.45.

About IDEX

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company's core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.